Clinical Trials
17 trialsNCT06525220 2026-06-02
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Merus B.V.
Phase 3 Recruiting
NCT06256588 2026-05-26
JADE
GlaxoSmithKline
Phase 3 Recruiting
NCT07264075 2026-05-20
ILLUMINE
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Recruiting
NCT06641791 2026-05-12
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT05187091 2026-05-04
SWOAR
All India Institute of Medical Sciences
Phase 3 Recruiting
NCT06706401 2026-04-24
LYSARI
Centre Leon Berard
Phase 3 Recruiting
NCT07445048 2026-04-17
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 3 Recruiting
NCT06915727 2026-04-01
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting
NCT07467083 2026-04-01
Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
West China Hospital
Phase 3 Recruiting
NCT07333274 2026-01-12
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Shandong Cancer Hospital and Institute
Phase 3 Recruiting
NCT06998069 2025-12-30
Head and Neck Cancer Study Project in the Geriatric Population
Brown University
Phase 3 Recruiting
NCT05333523 2025-11-24
PRIMO
Radboud University Medical Center
Phase 3 Recruiting
NCT05273307 2025-09-22
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
University of California, San Francisco
Phase 3 Recruiting
NCT06055257 2025-09-12
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
Sunnybrook Health Sciences Centre
Phase 3 Recruiting
NCT05078047 2025-06-05
MOIO
UNICANCER
Phase 3 Recruiting
NCT04178174 2025-05-18
SHORT-OPC
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 3 Recruiting
NCT06737822 2025-03-04
SurVIC
All India Institute of Medical Sciences, Jodhpur
Phase 3 Recruiting